Theralase Technologies Inc. V.TLT

RE:CLARIFICATION NEEDED FROM CO.

[CancerSlayer]

Tarbaby wrote: By stating that Metformin can potentially activate Rutherrin in a patient with cancer to destroy that cancer even as an outpatient  does that not imply that Rutherrin is safe as a medicine given to a human along with Metformin..?? I read it that way.
This should be the BIGGEST NEWS in the entire cancer field and the stock should be soaring..whats wrong here..?

I feel you pain Tarbaby...the recent NRs in total represent incredible IP value (at minimum ) for such a small biotech.  Many standard investors cannot connect the dots at this stage, so consequently they'll wait to dive in until they see bigger signals of success & what I believe is inevitable, BTD & FDA approval.  But you & I know better...

As for Rutherrin, that portion called transferrin is truly our trojan horse...friendly to healthy cells, but deadly to cancer cells.  Using transferrin as our saddle/carrier should allow tremendous opportunity across multiple applications/indications.  

In cancer's hunger for iron, they tend to overexpress their transferrin receptors, which makes transferrin a ubiquitous & ideal carrier to combat cancer in general.  GBM & NSCLC are both highly dependent on upregulation of their transferrin receptors, which should bode well for our upcoming Rutherrin tox/clinical studies.  All imo.